Radiopharma drugmakers spoke with BioPharma Dive about chasing Novartis in the hot field, while investors debated the impact of a surprise FTC challenge.The mood shifts on the third day of the J.P. Morgan Healthcare Conference.Deals have been announced and news peters out. The most closely-watched companies have already presented. Investors and executives are worn down […]
